Role of PLP-Level as a predictive marker for oral health status in adult hypophosphatasia
Clinical Oral Investigations · 2024
DOI: 10.1007/s00784-024-05809-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Investigations, 2024. Verfasst von Florian Dudde und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestraße 59, 22529, Hamburg, Germany. Hauptthemen laut MEDLINE: Biomarkers, DMF Index, Hypophosphatasia, Oral Health. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).
Themen: Mundpflege
Abstract (Originalsprache)
Aim
The aim of this study was to investigate the role of pyridoxal-5-phosphate (PLP) level on the oral health status as a predictive marker in patients with hypophosphatasia (HPP). Materials and methods Throughout a systematic retrospective assessment both bone metabolism and oral health status were analyzed. The oral health status was assessed by the decayed/missing/filled teeth index (DMFT), clinical attachment level (CAL), probing pocket depth (PPD), and the periodontal screening index (PSI).
Results
A total of 48 HPP patients (81.3% female) with a mean age of 42.21 years was included in this retrospective study. The study population was divided into two groups using the mean PLP level (87 µg/l) as a cut-off. Patients with a PLP level ≥ 87 µg/l ( n = 14) showed a significantly poorer oral health status regarding DMFT index, CAL, PPD and PSI compared to patients with a PLP level < 87 µg/l ( n = 34). No significant group differences for tooth loss were found.
Conclusion
The results of the present study indicate that the PLP level is a suitable diagnostic predictor for the oral health status in HPP patients. HPP patients with PLP levels ≥ 70 µg/l should be included into a regular dental preventive program. Clinical Relevance The oral health status in HPP and its correlation with laboratory parameters (i.e. PLP) has been understudied. For clinical practice, the findings of the present study clearly demonstrated that high PLP levels correlate with a worse oral health status in HPP patients. Therefore, these patients should receive an intensive dental treatment and/or inclusion in a strict maintenance program in a specialized dental practice/university hospital with a PLP level ≥ 70 µg/l.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestraße 59, 22529, Hamburg, Germany.
- Department of Periodontics, Preventive and Restorative Dentistry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestraße 59, 22529, Hamburg, Germany. fbarvencik@uke.de.
Förderung
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Dudde, F., Fildebrandt, D., Smeets, R., Gosau, M., Amling, M., Beikler, T., & Barvencik, F. (2024). Role of PLP-Level as a predictive marker for oral health status in adult hypophosphatasia. Clinical Oral Investigations. https://doi.org/10.1007/s00784-024-05809-w
Vancouver
Dudde F, Fildebrandt D, Smeets R, Gosau M, Amling M, Beikler T, et al. Role of PLP-Level as a predictive marker for oral health status in adult hypophosphatasia. Clinical Oral Investigations. 2024. doi:10.1007/s00784-024-05809-w
BibTeX
@article{Dudde2024,
author = {Dudde, Florian and Fildebrandt, Dominik and Smeets, Ralf and Gosau, Martin and Amling, Michael and Beikler, Thomas and Barvencik, Florian},
title = {Role of PLP-Level as a predictive marker for oral health status in adult hypophosphatasia},
journal = {Clinical Oral Investigations},
year = {2024},
doi = {10.1007/s00784-024-05809-w}
}
EUVIMED